Current role of MR imaging in the staging of adenocarcinoma of the prostate

Mark L. Schiebler, Mitchell D. Schnall, Howard M. Pollack, Robert E. Lenkinski, John E. Tomaszewski, Alan J. Wein, Richard Whittington, Wolfgang Rauschning, Herbert Y. Kressel

Research output: Contribution to journalArticlepeer-review

127 Scopus citations


Surgical cure of adenocarcinoma of the prostate (ACP) is possible in over 80% of cases when the disease is confined to the gland capsule. The endorectal probe for magnetic resonance (MR) imaging has increased resolution of the prostate gland and capsule, which has improved the sensitivity and specificity for staging ACP (.65 sensitivity, .69 specificity for body coil; .87 sensitivity, .85 specificity for the endorectal coil). Normal glandular regions in the peripheral zone and central zone have significantly higher citrate levels than ACP and fibromuscular and fibrous benign prostatic hyperplasia at proton spectroscopy. ACP has a higher phosphomonoester-phosphocreatine ratio than normal glandular tissue at phosphorus spectroscopy. The combination of endorectal coil MR imaging for local spread, and body coil MR imaging for advanced disease, makes MR imaging the premier imaging modality for the preoperative staging of ACP.

Original languageEnglish (US)
Pages (from-to)339-352
Number of pages14
Issue number2
StatePublished - Nov 1993


  • Magnetic resonance (MR), spectroscopy
  • Prostate, MR, 844.12141, 844.12145
  • Prostate, neoplasms, 844.324
  • State-of-art reviews

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Current role of MR imaging in the staging of adenocarcinoma of the prostate'. Together they form a unique fingerprint.

Cite this